<DOC>
	<DOCNO>NCT02279511</DOCNO>
	<brief_summary>To Check whether systemic treatment ATP alters profile cerebral metabolism patient Alzheimer 's disease use MRS technique ( Magnetic Resonance Spectroscopy ) adjust infusion ( minimum effective dose ) promote metabolic change .</brief_summary>
	<brief_title>ATP Alzheimer Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<criteria>1 . Men woman age 5585 year 2 . Diagnosis possible probable Alzheimer disease accord NIAAA 2011 criterion . 3 . Global Deterioration Scale Stadium 56 / 155 Minimental State examination 4 . The patient live family primary caregiver caregiver train accompany adequate intervention followup visit . Patient caregiver knowledge local language sufficient . 5 . The patient caregiver willing participate study . There high probability patient caregiver complete study . 6 . The patient sensory deficit prevent evaluation . 7 . The patient receives stable Alzheimer Disease conventional medication . No change treatment least 90 day prior selection . 8 . The patient receive conventional stable medication possible comorbidities . No change treatment least 90 day prior selection . 9 . The subject legal representative give prior inform consent include genetic study Apolipoprotein E rs11870474 . 1 . Concomitant severe neurological disease Alzheimer Disease . 2 . Presence history psychiatric disorder emphasis positive behavioral disorder associate Alzheimer Disease ( aggressiveness , agitation , delusion , hallucination , anxiety ) . 3 . Current Severe systemic disease may prevent completion study . 4 . History STROKE . 5 . History convulsion use anticonvulsant . 6 . History myocardial infarction , angina pectoris , cardiac arrhythmias serious cardiovascular disorder congestive heart failure , valvular aneurysm . 7 . Background Diabetes mellitus / picture hypoglycemia . 8 . Uncontrolled hypertension ( systolic &gt; 160 mmHg / Diastolic &gt; 95 mmHg ) . 9 . Systemic hypotension ( SBP &lt; 86 mmHg ) bradycardia ( &lt; 50 beat per minute ) 10 . Bronchial Asthma History lung disease cause bronchospasm bronchoconstriction 11 . Kidney failure ( patient medical restriction income parenteral intake fluid ) . 12 . Liver failure . 13 . Respiratory failure ( need supplemental oxygen supply ) 14 . Blood donation last 90 day anemia ( Hb &lt; 10g/dL ) 15 . Use connection ( &lt; 30 day prior screen ) antidepressant , sedative hypnotic . 16 . Using Alzheimer Disease experimental drug last 60 day prior screen . 17 . Women pregnant fertile 18 . Inadequate venous access prevent parenteral administration infusion .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Alzheimer</keyword>
</DOC>